Improving Diagnosis of COPD Through Characterisation of Comorbidities Present at, and Healthcare Utilisation Prior to, Diagnosis of COPD in UK. A Retrospective Primary Care Database.
Sponsor study identifier
observational
38,859
1 country
1
Study Start
December 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2011
Actual (reported)Study Completion
June 2012
Actual (reported)To characterise and understand the current UK COPD population including demographics, active comorbidities and missed opportunities for COPD diagnosis in the years previous to diagnosis
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2012
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2010
Date type not reportedThis date has not been verified as actual or estimated.
February 2011
Actual (reported)June 2012
Actual (reported)July 31, 2012
Actual (reported)August 2, 2012
Actual (reported)All patients with a coded diagnosis of COPD entered into their electronic clinical record between 1990 and 2009.
Subjects aged 40 years or older, with an electronically coded diagnosis of COPD made between 1990 and 2009, a minimum of three years continuous practice data including two years prior to and one year post diagnosis to ensure patients recieved COPD therapy post diagnosis (defined as two or more prescriptions for COPD therapies in the 12 months post diagnosis year 1). COPD therapies included short- and long-acting bronchodilators, inhaled corticosteroids, theophylline and leukotriene receptor antagonists.
Research in Real Life Ltd
Cambridge, Cambridgeshire, CB24 3BA, United Kingdom
Jones RC, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, Burden A, Halpin DM, Winter R, Hill S, Kearney M, Holton K, Moger A, Freeman D, Chisholm A, Bateman ED; Respiratory Effectiveness Group. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med. 2014 Apr;2(4):267-76. doi: 10.1016/S2213-2600(14)70008-6. Epub 2014 Feb 13.
David B Price, MD
Research in Real-Life Ltd
Dermot Ryan, MBBS
University of Edinburgh
Rupert Jones, MBBS
Peninsula College of Medinicne and Dentistry
Eric Bateman, MD
University of Cape Town
38,859 participants (actual enrollment reported by the registry).
First Submitted
July 31, 2012
First Posted
August 2, 2012
Study Start
December 2010
Date type not reportedThis date has not been verified as actual or estimated.
Characteristics That Identify Exacerbation Risk Following Colds in COPD Patients
Contact the study team to confirm eligibility.
Matt Kearney, MPH
Department of Health, United Kingdom
Primary Completion
February 2011
Actual (reported)Study Completion
June 2012
Actual (reported)Last Updated
August 2, 2012
Record last verified: 2012-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: